Heartache in a Bottle: Understanding Alcoholic Cardiomyopathy

• Published in: Curēus (Palo Alto, CA) Vol. 15; no. 8; p. e42886
• Main Authors: Ihekire, Nkechinyere L, Okobi, Okelue E, Adedoye, Enoobong Aderonke, Akahara, Patience F, Onyekwere, Anita O, Afrifa-Yamoah, Jeffrey, Akinyemi, Falilatu B
• Format: Journal Article
• Language: English
• Published: Palo Alto Springer Nature B.V 03.08.2023; Cureus
• Subjects: Alcohol abuse; Alcohol use; Alcoholic beverages; Alcoholism; Cardiology; Cardiomyopathy; Disease; Family/General Practice; Heart failure; Internal Medicine; Ischemia; Literature reviews; Pathophysiology; Personal health; Physiology; Proteins
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.42886

Alcoholic cardiomyopathy (ACM) is a cardiac ailment marked by impaired contraction and dilation of one or both ventricles of the heart. The extent of daily alcohol intake and duration of alcohol abuse are linked to the development of ACM, although the exact thresholds and timeline for alcohol misuse to induce heart dysfunction remain uncertain. Thus, the objective of this systematic review is to comprehensively evaluate the existing knowledge on the specific disease entity, particularly in light of the ongoing issue of alcohol misuse, with the intention of determining if recent advancements and discoveries have significantly altered the understanding of this condition compared to the past century. This systematic review involved a literature search that was conducted on PubMed to identify suitable and appropriate literature for the study. The inclusion criteria encompassed articles that focused on ACM or the relationship between alcohol abuse and cardiac dysfunction, involved human subjects or relevant animal models, were written in the English language, and were published within the last 10 years. The exclusion criteria included duplicates, case reports, letters, editorials, and reviews not specifically addressing ACM. As a result, a total of 18 articles were included in this systematic review. The risk of bias was assessed through the use of the Cochrane risk-of-bias tool for clinical trials. The findings of this systematic review indicated that the likelihood of ACM occurrence significantly rose when the consumption of over 80 g of alcohol per day occurred for at least five years. The systematic review further revealed that ACM is associated with various detrimental changes in the cellular, structural, and histological aspects of the heart muscles, even though the specific clinical and histological characteristics of ACM have yet to be established. In individuals with an extensive history of excessive alcohol abuse, the diagnosis of ACM was reached through the exclusion of other potential causes of the condition. The fundamental approach to treatment lies in abstaining from alcohol. It is crucial to manage symptoms in individuals with secondary heart failure and address any related complications.